John M. Climaco Acquires 15,000 Shares of CNS Pharmaceutical

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) CEO John M. Climaco acquired 15,000 shares of the stock in a transaction dated Wednesday, April 12th. The stock was acquired at an average cost of $0.69 per share, with a total value of $10,350.00. Following the purchase, the chief executive officer now owns 45,010 shares of the […]

Related Keywords

Johnm Climaco , , Pharmaceuticals Price Performance , Pharmaceuticals Inc , Cns Pharmaceuticals Inc , Pharmaceuticals Daily , Virtu Financial , York Mellon Corp , Armistice Capital , Nasdaq , Renaissance Technologies , Get Rating , New York Mellon Corp , Cns Pharmaceuticals , Nasdaq Cnsp , Cnsp , Medical , Insider Trading , Nsider Trades , Stocks ,